uPA and PAI-1 ready for routine testing in primary breast cancer: pooled analysis (n = 8 377) provides level-1 evidence for clinical relevance. - Harbeck,N.; Look,M.P.; Ulm,K.; Duffy,M.J. (ASCO Proceedings, 2001)